Physician profile
Chen Jiang
NPI 1215666417
$3,560.25
in general payments reported to CMS, 2019-2025
11 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $286 · 2023: $794 · 2024: $1,134 · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,273.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,043.81 | 2022-2024 | Ams 700, Xpeeda Dsl Fiber, Solyx Sis System |
| Coloplast Corp | $1,018.89 | 2023-2025 | Titan, Isiris Astent Removal Device |
| Teleflex LLC | $556.85 | 2025 | Barrigel, Urolift |
| Olympus America INC. | $271.75 | 2023-2024 | Itind System, Olympus |
| Calyxo, INC. | $244.20 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $118.97 | 2024 | Axonics, Bulkamid |
| Janssen Scientific Affairs, LLC | $113.57 | 2024-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $111.18 | 2025 | |
| Photocure INC | $33.33 | 2025 | Cysview |
| Abbvie INC. | $30.80 | 2025 | Botox |
| Pfizer INC. | $16.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chen Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.